Related Experiment Video
Updated: Aug 8, 2025

Whole Genome Sequencing of Candida glabrata for Detection of Markers of Antifungal Drug Resistance
Published on: December 28, 2017
Draft Genome Sequence of a Preterm Infant-Derived Isolate of Candida parapsilosis
Steve A James1, Andrea Telatin1, David Baker1
1Gut Microbes and Health Research Programme, Quadram Institute Bioscience, Norwich, United Kingdom.
Abstract:
Candida parapsilosis is a human fungal pathogen of increasing incidence and causes invasive candidiasis, notably in preterm or low-birthweight neonates. Here, we present the genome sequence of C. parapsilosis NCYC 4289, a fecal isolate from a preterm male infant.
Insights
We sequenced the genome of Candida parapsilosis, a fungal pathogen causing infections in premature infants. This provides a valuable resource for understanding and combating neonatal candidiasis.
Area of Science:
- Mycology
- Genomics
- Neonatal Infectious Diseases
Background:
- Candida parapsilosis is a significant human fungal pathogen.
- Its incidence, particularly in invasive infections, is increasing globally.
- Neonates, especially preterm and low-birthweight infants, are highly susceptible to candidiasis.
Purpose of the Study:
- To present the complete genome sequence of Candida parapsilosis strain NCYC 4289.
- To provide a genomic resource for C. parapsilosis research.
- To facilitate studies on the pathogenesis and epidemiology of this important fungal pathogen in vulnerable populations.
Main Methods:
- Whole-genome sequencing of Candida parapsilosis NCYC 4289.
- Bioinformatic analysis and genome assembly.
- Characterization of the fecal isolate from a preterm infant.
Main Results:
- The genome sequence of C. parapsilosis NCYC 4289 was successfully obtained and assembled.
- This represents a key genomic dataset for a clinically relevant strain.
- The isolate was confirmed as a fecal sample from a preterm male infant.
Conclusions:
- The availability of the C. parapsilosis NCYC 4289 genome sequence is a significant advancement.
- This genomic data will aid in understanding the genetic basis of C. parapsilosis virulence and antifungal resistance.
- It will support the development of targeted interventions against neonatal candidiasis.

